MicroRNAs: Are they the missing link between hypoxia and pre-eclampsia?

Hypertension in Pregnancy

Volumn 33, Issue 1, 2014, Pages 102-114

  Li, Jordan Y Z ^a   Yong, Tuck Y ^b   Michael, Michael Z ^b   Gleadle, Jonathan M ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Exosomes; Hypoxia; MicroRNA; Placenta; Pre eclampsia

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; PLACENTAL MICRORNA; UNCLASSIFIED DRUG;

EXOSOME; GENE CONTROL; HUMAN; HYPOXIA; PLACENTA CIRCULATION; PREECLAMPSIA; PROGNOSIS; REVIEW; RNA REPLICATION; ANOXIA; FEMALE; METABOLISM; PLACENTA; PREGNANCY;

ANOXIA; EXOSOMES; FEMALE; HUMANS; MICRORNAS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY;

EID: 84891520273     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641955.2013.832772     Document Type: Review

References (89)

1. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatal 2009; 33:130-7.
2. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systemic review and meta-analysis. BMJ 2007;335:974.
3. Viske BE, Irgens LM, Leivestad T, et al. Preeclampsia and the risk of end-stage renal disease. N Engl J Med 2008;359:800-9.
4. Rusterholz C, Messerli M, Hoesli I, Hahn S. Placental microparticles, DNA and RNA in pre-eclampsia. Hypertens Pregnancy 2011;30:364-75.
5. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136: 215-33.
6. Karp X, Ambros V. Developmental biology. Encountering microRNAs in cell fate signalling. Science 2005;310:1288-9. (Pubitemid 41698853)
7. Guarnieri DJ, Dileone RJ. MicroRNAs: a new class of gene regulators. Ann Med 2008;40:197-208. (Pubitemid 351482548)
8. Leung AK, Sharp PA. MicroRNAs: a safe-guard against turmoil? Cell 2007;130: 581-5.
9. Lee Y, Kim M, Han J, et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004;23:4051-60. (Pubitemid 39472426)
10. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011;39:D152-7.
11. Kulshreshtha R, Davuluri RV, Calin GA, Ivan M. A microRNA component of hypoxic response. Cell Death Differ 2008;15:667-71.
12. Camps C, Butta FM, Coletta S, et al. hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 2008;14:1340-8. (Pubitemid 351413913)
13. Fasanaro P, D'Alessandra Y, Di Stefano V, et al. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine-kinase ligand Ephrin-A3. J Biol Chem 2008;283:15878-83.
14. van der Post JA, Lok CA, Boer K, et al. The functions of microparticles in preeclampsia. Semin Thromb Hemost 2011;37:146-52.
15. Redman CW, Sargent IL. Circulating microparticles in normal pregnancy and preeclampsia. Placenta 2008;29:S73-7.
16. Redman CW, Tannetta DS, Dragovic RA, et al. Review: does size matter? Placental debris and the pathophysiology of pre-eclampsia. Placenta 2012;33: S48-54.
17. Donker RB, Mouillet JF, Nelson DM, Sadovsky Y. The expression of Argonaute2 and related microRNA biogenesis proteins in normal and hypoxic trophoblasts. Mol Hum Reprod 2007;12:273-9. (Pubitemid 46554745)
18. Yang WJ, Yang DD, Na S, et al. Dicer is required for embryonic angiogenesis during mouse development. J Biol Chem 2005;280:9330-5. (Pubitemid 40409626)
19. Morita S, Horii T, Kimura M, et al. One Argonaute family member, Eif2c2 (Ago 2), is essential for development and appears not to be involved in DNA methylation. Genomics 2007;89:687-96. (Pubitemid 46719793)
20. Chakrabarty A, Tranguch S, Daikoku T, et al. MicroRNA regulation of cyclooxygenase-2 during embryo implantation. Proc Natl Acad Sci USA 2007;104: 15144-9. (Pubitemid 47619608)
21. Veit TD, Chies JA. Tolerance versus immune response-microRNAs as important elements in the regulation of HLA-G gene expression. Transpl Immunol 2009;20: 229-31.
22. Luo SS, Ishibashi O, Ischikawa G, et al. Human villous trophoblast express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol Reprod 2009;81:717-29.
23. Landgraf P, Rusu M, Cheridan R, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007;129:1401-14. (Pubitemid 46970709)
24. Liang Y, Ridzon D, Wong L, Chen C. Characterisation of microRNA expression profiles in normal human tissues. BMC Genomics 2007;8:166.
25. Miura K, Miura S, Yamasaki K, et al. Identification of pregnancy-associated microRNAs in maternal plasma. Clin Chem 2010;56:1767-71.
26. Noguer-Dance M, Abu-Amero S, Al-Khtib M, et al. The primate-specific microRNA gene cluster (C19MC) is imprinted in the placenta. Hum Mol Genet 2010;19: 3566-82.
27. Berkane N, Lefevre G, Hertig A. Angiogenic factors in pre-eclampsia: so complex, so simple? Nephrol Dial Transplant 2007;22:2753-6. (Pubitemid 350093464)
28. Brosens IA, Robertson WB, Dixon HG. The role of spiral arteries in the pathogenesis of pre-eclampsia. Obstet Gynecol Annu 1972;1:177-91.
29. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human placental development by oxygen tension. Science 1997;277:1669-72. (Pubitemid 27446230)
30. Adelman DM, Gertsenstein M, Nagy A, et al. Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses. Genes Dev 2000;14:3191-203. (Pubitemid 32015136)
31. Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response - a review. Placenta 2003;24:S21-7. (Pubitemid 37184731)
32. Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in pre-eclampsia. N Engl J Med 2006;355:992-1005. (Pubitemid 44343543)
33. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension and proteinuria in pre-eclampsia. J Clin Invest 2003;111:649-58. (Pubitemid 36278583)
34. Kulshreshtha R, Ferracin M, Negrini M, et al. Regulation of microRNA expression: the hypoxic component. Cell Cycle 2007;6:1426-31.
35. Hua Z, Lv Q, -e W, et al. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 2006;1:e116.
36. Hebert C, Norris K, Scheper MA, et al. High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol Cancer 2007;6:5.
37. Pineles BL, Romero R, Montenegro D, et al. Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with pre-eclampsia. Am J Obstet Gynecol 2007;196:261.e1-6.
38. Mouillet JF, Chu T, Nelson DM, et al. MiR-205 silences MED1 in hypoxic primary human trophoblasts. FASEB J 2010;24:2030-9.
39. Zhang Y, Fei M, Xue G, et al. Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: new insights into molecular mechanisms for the disease. J Cell Mol Med 2012;16:249-59.
40. Gellhaus A, Schmidt M, Dunk C, et al. Decreased expression of the angiogenic regulation CYR61 (CCN1) and NOV (CCN3) in human placenta is associated with pre-eclampsia. Mol Hum Reprod 2006;12:389-99. (Pubitemid 43985610)
41. Enquobahrie DA, Abetew DF, Sorensen TK, et al. Placental microRNA expression in pregnancies complicated by pre-eclampsia. Am J Obstet Gynecol 2011;204: 178.e12-21.
42. Donker RB, Mouillet JF, Chu T, et al. The expression profile of C19MC microRNAs in primary human trophoblast cells and exosomes. Mol Hum Reprod 2012;18: 417-24.
43. Dunwoodie SL. The role of hypoxia in development of the mammalian embryo. Dev Cell 2009;17:755-73.
44. Harris AL. Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2002;2:38-47. (Pubitemid 37328806)
45. Lee DC, Romero R, Kim JS, et al. MiR-210 targets iron-sulfur cluster scaffold homologue in human trophoblast cell lines. Am J Path 2011;179:590-602.
46. Rouault TA, Tong WH. Iron-sulfur cluster biogenesis and human disease. Trends Genet 2008;24:398-407.
47. Chan SY, Zhang Y-Y, Hemann C, et al. MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab 2009;10:273-84.
48. Favaro E, Ramachandran A, McCormick R, et al. MicroRNA-210 regulates mitochondrial free radical response to hypoxia and Krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU. PLoS One 2010;5:e10345.
49. Muralimanoharan S, Maloyan A, Mele J, et al. MIR-210 modulates mitochondrial respiration in placenta with pre-eclampsia. Placenta 2012;33:816-23.
50. Ishibashi O, Ohkuchi A, Ali M, et al. Hydroxysteroid (17-b) dehydrogenase 1 is dysregulated by Mir-210 and Mir-518c that are aberrantly expressed in preeclamptic placentas. Hypertension 2012;59:265-73.
51. Peltoketo H, Vihko P, Vihko R. Regulation of estrogen action: role of 17 b-dehydroxysteroid dehydrogenases. Vitam Horm 1999;55:353-98.
52. Wang E, Feng L, Zhang H, et al. Pre-eclampsia up-regulates angiogenesisassociated microRNA (ie miR-17, -20a, and -20b) that target Ephrin-B2 and PHB4 in human placenta. J Clin Endocrinol Metab 2012;97:E1051-9.
53. Zhang Y, Diao Z, Su L, et al. MicroRNA-155 contributes to pre-eclampsia by downregulating CYR61. Am J Obstet Gynecol 2010;202:466.e1-7.
54. Hu Y, Li P, Hao S, et al. Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia. Clin Chem Lab Med 2009;47:923-9.
55. Zhu XM, Han T, Sargent IL, et al. Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs. normal pregnancies. Am J Obstet Gynecol 2009;200:661.e1-7.
56. Keniry A, Oxley D, Monnier P, et al. The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r. Nat Cell Biol 2012;14:659-65.
57. Guo L, Yang Q, Lu J, et al. A comprehensive survey of miRNA repertoire and 30 addition events in the placentas of patients with pre-eclampsia from highthroughput sequencing. PLoS One 2011;6:e21072.
58. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008;105: 10513-18.
59. Valadi H, Ekstrom K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007;9:654-9. (Pubitemid 47214727)
60. Gilad SG, Meiri E, Yogev, Y, et al. Serum microRNAs are promising novel biomarkers. PLoS One 2008;3:e3148.
61. Camussi G, Deregibus MC, Bruno S, et al. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 2010;78:838-48.
62. Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011;108:5003-8.
63. Vickers KC, Palmisano BT, Shoucri BM, et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011;13:423-33.
64. Hunter MP, Ismail N, Zhang X, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008;3:e3694.
65. Chim SS, Shing TK, Hung EC, et al. Detection and characterization of placental micorNAs in maternal plasma. Clin Chem 2008;54:482-90. (Pubitemid 351348154)
66. Luo SS, Ishibashi O, Ishikawa G, et al. Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol Reprod 2009;37:766-70.
67. Miura K, Miura S, Yamasaki K, et al. Identification of pregnancy-associated microRNAs in maternal plasma. Clin Chem 2010;56:1767-71.
68. Gunel T, Zeybek -G, Akcakaya P, et al. Serum microRNA expression in pregnancies with pre-eclampsia. Genet Mol Res 2011;10:4034-40.
69. Wu L, Zhou H, Lin H, et al. Circulating microRNAs are elevated in plasma from severe pre-eclapmtic pregnancies. Reproduction 2012;143:389-97.
70. Keller S, Rupp C, Stoeck A, et al. CD24 is a marker of exosomes secreted into urine and amniotic fluid. Kidney Int 2007;72:1095-102. (Pubitemid 47609042)
71. Bard MP, Hegmans JP, Hemmes A, et al. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am J Respir Cell Mol Biol 2004;31: 114-21. (Pubitemid 38888047)
72. Taylor DD, Akyol S, Gercel-Taylor C. Pregnancy-associated exosomes and their modulation of T cell signalling. J Immunol 2006;176:1534-42. (Pubitemid 43134297)
73. Mincheva-Nilsson L, Baranov V. The role of placental exosomes in reproduction. Am J Reprod Immunol 2010;63:520-33.
74. Atay S, Gercel-Taylor C, Suttles J, et al. Trophoblast-derived exosomes mediate monocyte recruitment and differentiation. Am J Reprod Immunol 2011;65:65-77.
75. Knight M, Redman CW, Linton EA, Sargent IL. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol 1998;105:632-40. (Pubitemid 28293481)
76. Goswami D, Tannetta DS, Magee LA, et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta 2006;27:56-61. (Pubitemid 41662880)
77. Lok CA, Boing AN, Sargent IL, et al. Circulating platelet-derived and placentaderived microparticles expose Flt-1 in pre-eclampsia. Reprod Sci 2008;15:1002-10.
78. Baumann MU, Bersinger NA, Surbek DV. Serum markers for predicting preeclampsia. Mol Aspects Med 2007;28:227-44.
79. Savvidou MD, Yu CK, Harland LC, et al. Maternal serum concerntration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factors in women with abnormal uterine aetry Doppler and in those with fetal growth restriction. Am J Obstet Gynecol 2006;195:1668-73. (Pubitemid 44792614)
80. Than NG, Romero R, Hillermann R, et al. Prediction of pre-eclampsia - a workshop report. Placenta 2008;29:S83-5.
81. Esau C, Davis S, Murray SF, et al. MiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006;3:87-98.
82. Janssen HL, Reesink HW, Lawitz EJ, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med 2013;368:1685-94.
83. Elmen J, Lindow M, Silahtaroglu A, et al. Antagonism of microRNA-122 in mice by systematically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 2008;36:1153-62. (Pubitemid 351330933)
84. Krutzfeldt J, Rajewsky N, Braich R, et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005;438:685-9.
85. Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007;4:721-6. (Pubitemid 47338166)
86. Si ML, Zhu S, Wu H, et al. miR-21-mediated tumor growth. Oncogene 2007;26: 2799-803. (Pubitemid 46663837)
87. Hu S, Huang M, Li Z, et al. MicroRNA-210 as a novel therapy for treatment of ischaemic heart disease. Circulation 2010;122:S124-31.
88. Noack F, Ribbat-Idel J, Thorns C, et al. miRNA expression profiling in formalinfixed and paraffin-embedded placental tissue samples from pregnancies with severe preeclampsia. J Perinat Med 2011;39:267-71.
89. Mayor-Lynn K, Toloubeydokhti T, Cruz AC, Chegini N. Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor. Reprod Sci 2011;18:46-56.